DK391189A - Carbostyrilderivater - Google Patents

Carbostyrilderivater Download PDF

Info

Publication number
DK391189A
DK391189A DK391189A DK391189A DK391189A DK 391189 A DK391189 A DK 391189A DK 391189 A DK391189 A DK 391189A DK 391189 A DK391189 A DK 391189A DK 391189 A DK391189 A DK 391189A
Authority
DK
Denmark
Prior art keywords
carbostyril derivatives
carbostyril
derivatives
Prior art date
Application number
DK391189A
Other languages
Danish (da)
English (en)
Other versions
DK391189D0 (da
Inventor
Takafumi Fujioka
Shuji Teramoto
Michiaki Tominaga
Yoichi Yabuuchi
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Publication of DK391189D0 publication Critical patent/DK391189D0/da
Publication of DK391189A publication Critical patent/DK391189A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20Oxygen atoms
    • C07D215/22Oxygen atoms attached in position 2 or 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20Oxygen atoms
    • C07D215/22Oxygen atoms attached in position 2 or 4
    • C07D215/227Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
DK391189A 1988-08-10 1989-08-09 Carbostyrilderivater DK391189A (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP20092988 1988-08-10
JP3468889 1989-02-14
JP16017089 1989-06-21

Publications (2)

Publication Number Publication Date
DK391189D0 DK391189D0 (da) 1989-08-09
DK391189A true DK391189A (da) 1990-02-11

Family

ID=27288505

Family Applications (1)

Application Number Title Priority Date Filing Date
DK391189A DK391189A (da) 1988-08-10 1989-08-09 Carbostyrilderivater

Country Status (7)

Country Link
US (2) US5053514A (ko)
EP (1) EP0355583B1 (ko)
JP (1) JP2648970B2 (ko)
KR (1) KR0139626B1 (ko)
DE (1) DE68920797T2 (ko)
DK (1) DK391189A (ko)
ES (1) ES2070151T3 (ko)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5198448A (en) * 1988-08-10 1993-03-30 Otsuka Pharmaceutical Company, Limited Cardiotonics
US5082847A (en) * 1990-07-18 1992-01-21 Syntex (U.S.A.) Inc. Carbostyril compounds connected via an oxyalkyl group with a piperidine ring and having pharmaceutical utility
TW201305B (ko) * 1991-04-03 1993-03-01 Otsuka Pharma Co Ltd
CA2093633A1 (en) * 1991-08-23 1993-02-24 Seiji Sato Carbostyril derivative and platelets aggregation inhibitory agent
JPH06183976A (ja) * 1992-09-18 1994-07-05 Otsuka Pharmaceut Co Ltd 抗不整脈剤
US5654317A (en) * 1992-09-18 1997-08-05 Otsuka Pharmaceutical Company, Limited Antiarrhythmic agent
TW254855B (ko) * 1993-07-28 1995-08-21 Otsuka Pharma Co Ltd
US5541204A (en) * 1994-12-02 1996-07-30 Bristol-Myers Squibb Company Aryloxypropanolamine β 3 adrenergic agonists
US5886010A (en) * 1995-01-09 1999-03-23 Otsuka Pharmaceutical Company, Limited TNF-αinhibitor
US6818660B2 (en) 1996-04-09 2004-11-16 Nps Pharmaceuticals, Inc. Calcilytic compounds
EA002984B1 (ru) * 1996-04-09 2002-12-26 Эн Пи Эс Фармасьютикалз, Инк. Кальцилитические соединения, фармацевтические композиции и способ скрининга кальцилитических соединений
TW483881B (en) 1996-12-03 2002-04-21 Nps Pharma Inc Calcilytic compounds
US7202261B2 (en) 1996-12-03 2007-04-10 Nps Pharmaceuticals, Inc. Calcilytic compounds
EP1017691A1 (en) * 1997-09-24 2000-07-12 Orion Corporation (Orion-Yhtyma Oy) Bisethers of 1-oxa, aza and thianaphthalen-2-ones as phospholamban inhibitors
HU227441B1 (en) 1997-11-24 2011-06-28 Egis Gyogyszergyar Nyilvanosan Muekoedoe Reszvenytarsasag Process for producing carvedilol, enantiomers and salts thereof
US7053092B2 (en) 2001-01-29 2006-05-30 Otsuka Pharmaceutical Co., Ltd. 5-HT1a receptor subtype agonist
US8703772B2 (en) 2001-09-25 2014-04-22 Otsuka Pharmaceutical Co., Ltd. Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
AR033485A1 (es) 2001-09-25 2003-12-26 Otsuka Pharma Co Ltd Sustancia medicinal de aripiprazol de baja higroscopicidad y proceso para la preparacion de la misma
EP1565472A2 (en) * 2002-11-27 2005-08-24 Artesian Therapeutics, Inc. Compounds with mixed pde-inhibitory and beta-adrenergic antagonist or partial agonist activity for treatment of heart failure
JP2006513222A (ja) * 2002-12-23 2006-04-20 アルテシアン セラピューティック,インコーポレイティド アドレナリン性β受容体およびホスホジエステラーゼに対する抑制活性を有する強心性化合物
TWI481601B (zh) * 2009-08-21 2015-04-21 Otsuka Pharma Co Ltd 含氮化合物及藥學組成物
KR102015054B1 (ko) * 2015-08-10 2019-08-27 동우 화인켐 주식회사 네가티브형 감광성 수지 조성물

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1058822A (en) * 1963-07-30 1967-02-15 Ici Ltd 3-amino-2-hydroxypropoxy heterocyclic derivatives
JPS517672B2 (ko) * 1972-04-13 1976-03-10
JPS4951271A (ko) * 1972-09-28 1974-05-18
JPS5241270B2 (ko) * 1973-01-25 1977-10-17
JPS5082218A (ko) * 1973-11-10 1975-07-03
JPS539227B2 (ko) * 1973-12-26 1978-04-04
US4210753A (en) * 1976-03-17 1980-07-01 Otsuka Pharmaceutical Co., Ltd. Carbostyril compounds
DE2805404A1 (de) * 1978-02-09 1979-08-16 Merck Patent Gmbh 1-aryloxy-3-nitratoalkylamino-2-propanole und verfahren zu ihrer herstellung
JPS54151985A (en) * 1978-05-17 1979-11-29 Otsuka Pharmaceut Co Ltd Preparation of aminocarbostyril derivative
AU518814B2 (en) * 1979-01-30 1981-10-22 Otsuka Pharamaceutical Co. Glaucoma treatment
DD150456A5 (de) * 1979-03-01 1981-09-02 Ciba Geigy Ag Verfahren zur herstellung von derivaten des 3-amino-1,2-propandiols
JPS55129268A (en) * 1979-03-28 1980-10-06 Otsuka Pharmaceut Co Ltd Carbostyril derivative
JPS5695115A (en) * 1979-12-28 1981-08-01 Otsuka Pharmaceut Co Ltd Remedy for glaucoma
JPS568319A (en) * 1980-03-26 1981-01-28 Otsuka Pharmaceut Co Ltd Antihistamine
JPS5780322A (en) * 1980-11-05 1982-05-19 Otsuka Pharmaceut Co Ltd Cardiotonic agent
DE3330005A1 (de) * 1983-08-19 1985-02-28 Wolfgang Dr. Graz Lindner Weinsaeuremonoester von optisch aktiven alkanolaminen, verfahren zu ihrer herstellung und ihre verwendung
GB2163150B (en) * 1984-07-19 1988-05-25 Sandoz Ltd 3-aminopropoxyaryl derivatives
ES2053480T3 (es) * 1986-07-31 1994-08-01 Otsuka Pharma Co Ltd Un procedimiento para preparar un derivado de carboestirilo.

Also Published As

Publication number Publication date
DK391189D0 (da) 1989-08-09
EP0355583A3 (en) 1991-11-06
KR0139626B1 (ko) 1998-06-01
JPH0386864A (ja) 1991-04-11
DE68920797D1 (de) 1995-03-09
US5385914A (en) 1995-01-31
JP2648970B2 (ja) 1997-09-03
EP0355583B1 (en) 1995-01-25
EP0355583A2 (en) 1990-02-28
ES2070151T3 (es) 1995-06-01
KR900003127A (ko) 1990-03-23
US5053514A (en) 1991-10-01
DE68920797T2 (de) 1995-06-29

Similar Documents

Publication Publication Date Title
DE68925405D1 (de) Carbostyril-Derivate
DK0382185T3 (da) Carbostyrilderivater
DE68925161T2 (de) Alkylavermectin-Derivate
DK391189A (da) Carbostyrilderivater
DE68927948T2 (de) Trehalosderivate
DK19789A (da) Dehydrocholcalciferolderivater
DK507188A (da) Cholecalciferolderivater
DE68927657D1 (de) Butynylaminderivate
DK80890A (da) Thien-triazol-diazepin-derivater
DK378088D0 (da) Alkenderivater
DK82189A (da) Substituerede quinolinderivater
DK81989D0 (da) Substituerede quinolinderivater
DK486089D0 (da) Pyranobenzoxadiazolderivater
DK0432275T3 (da) Substituerede bicykloheptandionderivater
DK49688A (da) Propiolophenonderivater
DE3824433A1 (de) Fluorcyclopropyl-derivate
DK160389A (da) Aryldionderivater
DK271088D0 (da) Tienopyridinderivater
DE68927179D1 (de) Carbostyril-derivate
ATA155589A (de) Mitomycinphosphat-derivate
DK82089D0 (da) Substituerede quinolinderivater
DK324489D0 (da) Substituerede azacyclohexylderivater
DE333073T1 (de) N-cycloalkylaminoethylbenzamid derivate
DK322489A (da) 1-normonylderivater
DK313789A (da) Thiadiazinonderivater

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment